Biomarker Discovery & Validation
News on biomarker discovery and validation for research and diagnostic use in genetics, genomics, and molecular diagnostics.
The firm is offering its epiCervix assay in the US as a laboratory-developed test to be used alongside human papillomavirus screening.
Direct-to-consumer microbiome tests often go beyond what the research can support, but the large databases being generated by some companies are supporting diagnostic development.
The company sees a clearer path to clinical validation and reimbursement through molecules that more directly measure how drugs affect the brain.
Thermo Fisher Scientific Gets FDA Clearance for Preeclampsia Risk Assessment Assays
A ratio of the two biomarkers detected by the 30-minute clinical chemistry assays can be used for prognosis and treatment of preeclampsia.
Mainz Biomed, Microba Life Sciences Partner to Develop Pancreatic Cancer Screening Test
The partners will collaborate to develop novel microbiome biomarkers for a screening test in development called PancAlert.